Abstract
Herpesvirus-associated ubiquitin-specific protease (HAUSP) regulates the stability of p53 and the p53-binding protein MDM2, implicating HAUSP as a therapeutic target for tuning p53-mediated antitumor activity. Here we report the structural analysis of HAUSP with Kaposi's sarcoma–associated herpesvirus viral interferon (IFN) regulatory factor 4 (vIRF4) and the discovery of two vIRF4-derived peptides, vif1 and vif2, as potent and selective HAUSP antagonists. This analysis reveals a bilateral belt-type interaction that results in inhibition of HAUSP. The vif1 peptide binds the HAUSP TRAF domain, competitively blocking substrate binding, whereas the vif2 peptide binds both the HAUSP TRAF and catalytic domains, robustly suppressing its deubiquitination activity. Peptide treatments comprehensively blocked HAUSP, leading to p53-dependent cell-cycle arrest and apoptosis in culture and to tumor regression in xenograft mouse model. Thus, the virus has developed a unique strategy to target the HAUSP–MDM2–p53 pathway, and these virus-derived short peptides represent biologically active HAUSP antagonists.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Martins, C.P., Brown-Swigart, L. & Evan, G.I. Modeling the therapeutic efficacy of p53 restoration in tumors. Cell 127, 1323–1334 (2006).
Ventura, A. et al. Restoration of p53 function leads to tumour regression in vivo. Nature 445, 661–665 (2007).
Brown, C.J., Cheok, C.F., Verma, C.S. & Lane, D.P. Reactivation of p53: from peptides to small molecules. Trends Pharmacol. Sci. 32, 53–62 (2011).
Lain, S. et al. Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator. Cancer Cell 13, 454–463 (2008).
Yang, Y. et al. Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells. Cancer Cell 7, 547–559 (2005).
Wade, M., Wang, Y.V. & Wahl, G.M. The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol. 20, 299–309 (2010).
Everett, R.D. et al. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J. 16, 1519–1530 (1997).
Lee, J.T. & Gu, W. The multiple levels of regulation by p53 ubiquitination. Cell Death Differ. 17, 86–92 (2010).
Brooks, C.L., Li, M., Hu, M., Shi, Y. & Gu, W. The p53–Mdm2–HAUSP complex is involved in p53 stabilization by HAUSP. Oncogene 26, 7262–7266 (2007).
Cummins, J.M. & Vogelstein, B. HAUSP is required for p53 destabilization. Cell Cycle 3, 689–692 (2004).
Cummins, J.M. et al. Tumour suppression: disruption of HAUSP gene stabilizes p53. Nature 428, 428 (2004).
Meulmeester, E. et al. Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2. Mol. Cell 18, 565–576 (2005).
Hu, M. et al. Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53–MDM2 pathway. PLoS Biol. 4, e27 (2006).
Sheng, Y. et al. Molecular recognition of p53 and MDM2 by USP7/HAUSP. Nat. Struct. Mol. Biol. 13, 285–291 (2006).
Saridakis, V. et al. Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol. Cell 18, 25–36 (2005).
Holowaty, M.N. et al. Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7. J. Biol. Chem. 278, 29987–29994 (2003).
Uetz, P. et al. Herpesviral protein networks and their interaction with the human proteome. Science 311, 239–242 (2006).
Sarkari, F. et al. Further insight into substrate recognition by USP7: structural and biochemical analysis of the HdmX and Hdm2 interactions with USP7. J. Mol. Biol. 402, 825–837 (2010).
Dong, A. et al. In situ proteolysis for protein crystallization and structure determination. Nat. Methods 4, 1019–1021 (2007).
Lee, H.R. et al. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathway. J. Virol. 83, 6739–6747 (2009).
Min, C.K. et al. Role of amphipathic helix of a herpesviral protein in membrane deformation and T cell receptor downregulation. PLoS Pathog. 4, e1000209 (2008).
Komander, D., Clague, M.J. & Urbe, S. Breaking the chains: structure and function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 10, 550–563 (2009).
Wadia, J.S., Stan, R.V. & Dowdy, S.F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10, 310–315 (2004).
Gump, J.M. & Dowdy, S.F. TAT transduction: the molecular mechanism and therapeutic prospects. Trends Mol. Med. 13, 443–448 (2007).
Petre, C.E., Sin, S.H. & Dittmer, D.P. Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy. J. Virol. 81, 1912–1922 (2007).
Katano, H., Sato, Y. & Sata, T. Expression of p53 and human herpesvirus-8 (HHV-8)-encoded latency-associated nuclear antigen with inhibition of apoptosis in HHV-8-associated malignancies. Cancer 92, 3076–3084 (2001).
Bhatia, K. et al. Hemi- or homozygosity: a requirement for some but not other p53 mutant proteins to accumulate and exert a pathogenetic effect. FASEB J. 7, 951–956 (1993).
Zhang, R., Wang, H. & Agrawal, S. Novel antisense anti-MDM2 mixed-backbone oligonucleotides: proof of principle, in vitro and in vivo activities, and mechanisms. Curr. Cancer Drug Targets 5, 43–49 (2005).
Kruse, J.P. & Gu, W. Modes of p53 regulation. Cell 137, 609–622 (2009).
Bunz, F. et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497–1501 (1998).
Keller, S.A. et al. NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. Blood 107, 3295–3302 (2006).
Lee, J.S. et al. FLIP-mediated autophagy regulation in cell death control. Nat. Cell Biol. 11, 1355–1362 (2009).
Wu, W., Rochford, R., Toomey, L., Harrington, W. Jr. & Feuer, G. Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferon-alpha. Leuk. Res. 29, 545–555 (2005).
Lee, H.R., Lee, S., Chaudhary, P.M., Gill, P. & Jung, J.U. Immune evasion by Kaposi′s sarcoma-associated herpesvirus. Future Microbiol. 5, 1349–1365 (2010).
Lee, H.R., Kim, M.H., Lee, J.S., Liang, C. & Jung, J.U. Viral interferon regulatory factors. J. Interferon Cytokine Res. 29, 621–627 (2009).
Sivachandran, N., Sarkari, F. & Frappier, L. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathog. 4, e1000170 (2008).
Du, Z. et al. DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination. Sci. Signal. 3, ra80 (2010).
De Marzo, A.M. et al. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res. 59, 3855–3860 (1999).
Agoston, A.T. et al. Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer. J. Biol. Chem. 280, 18302–18310 (2005).
Bronner, C. Control of DNMT1 abundance in epigenetic inheritance by acetylation, ubiquitylation, and the histone code. Sci. Signal. 4, pe3 (2011).
Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997).
Vagin, A. & Teplyakov, A. MOLREP: an automated program for molecular replacement. J. Appl. Cryst. 30, 1022–1025 (1997).
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).
Murshudov, G.N., Vagin, A.A. & Dodson, E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53, 240–255 (1997).
Laskowski, R.A., Moss, D.S. & Thornton, J.M. Main-chain bond lengths and bond angles in protein structures. J. Mol. Biol. 231, 1049–1067 (1993).
Acknowledgements
This work was partly supported by grants CA82057, CA31363, CA115284, CA147868, CA148616, DE019085, the Hastings Foundation, the Fletcher Jones Foundation, the William Lawrence and Blanche Hughes (WLBH) Foundation and the Global Research Laboratory (GRL) Program (K20815000001) from the National Research Foundation of Korea (J.U.J.); and the 21C Frontier Microbial Genomics and Applications Center Program and the National Research Foundation of Korea grant (NRF-M1AXA002-2010-0029767) funded by the Ministry of Education, Science and Technology, Korea (M.H.K.). We thank the staff at the 4A and 6B beamlines, Pohang Accelerator Laboratory, Korea, for help with data collection. We thank V. Lombardi, J. Jeong and J.S. Lee for their help. Finally, we thank all lab members for their support and discussions.
Author information
Authors and Affiliations
Contributions
H.-R.L. performed all aspect of this study; W.-C.C., J.H. and M.H.K. did X-ray crystallographic and biochemical studies; S.L. and Z.T. assisted with the experimental design and collected the data; E.H. and Y.H.J. carried out NMR studies; K.G. did protein purification; J.H. provided the KSHV library; H.-R.L., W.-C.C., T.-K.O., M.H.K. and J.U.J. organized this study and wrote the manuscript. All authors discussed the results and commented on the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Methods and Supplementary Figures 1–11 (PDF 14066 kb)
Rights and permissions
About this article
Cite this article
Lee, HR., Choi, WC., Lee, S. et al. Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein. Nat Struct Mol Biol 18, 1336–1344 (2011). https://doi.org/10.1038/nsmb.2142
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nsmb.2142
This article is cited by
-
USP7 Regulates Cytokinesis through FBXO38 and KIF20B
Scientific Reports (2019)
-
Identification and Characterization of USP7 Targets in Cancer Cells
Scientific Reports (2018)
-
Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases
Signal Transduction and Targeted Therapy (2018)
-
Protein deubiquitinase USP7 is required for osteogenic differentiation of human adipose-derived stem cells
Stem Cell Research & Therapy (2017)
-
HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma
Nature Medicine (2016)